Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in lupus 2006.

Arne Hansen1, Falk Hiepe, Thomas Dörner

  • 1Charité Centrum 12, Charité University Medicine, Chariteplatz 01, 10098 Berlin, Germany. arne.hansen@charite.de

Arthritis Research & Therapy
|July 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The conjugation-resistant bile acid norUDCA cures liver fibrosis but impairs systemic energy metabolism.

Molecular metabolism·2026
Same author

Selective Depletion of Autoreactive Plasma Cells as a Novel Strategy to Treat Acetylcholine Receptor Antibody-Positive Myasthenia Gravis.

European journal of immunology·2026
Same author

Increased Type I Interferon Activity with Concurrent Plasmablast Expansion Identifies Systemic Lupus Erythematosus Patients with Poor Outcomes.

International journal of molecular sciences·2026
Same author

Higher sensitivity to ouabain-induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes than human adult heart tissue despite similar Na<sup>+</sup>/K<sup>+</sup>-ATPase pump current amplitudes.

British journal of pharmacology·2026
Same author

Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.

Nature communications·2026
Same author

Distinct autoreactive CD19<sup>-</sup> plasma cell subsets accumulate in lupus-prone mice.

Nature communications·2025
Same journal

Alterations in systemic and skeletal muscle myostatin regulation are most prominent at disease onset and associate with muscle-related outcomes in idiopathic inflammatory myopathies.

Arthritis research & therapy·2026
Same journal

Plasma proteome differences between giant cell arteritis and polymyalgia rheumatica: a pilot study.

Arthritis research & therapy·2026
Same journal

Elucidating the mechanism of taurine in alleviating osteoarthritis progression based on bioinformatics, machine learning algorithm, and experimental validation.

Arthritis research & therapy·2026
Same journal

Discovery of biomarkers for primary Sj ögren's syndrome based on multi-omics data, construction of diagnostic models, and clinical correlation analysis.

Arthritis research & therapy·2026
Same journal

Identification of distinct subgroups in Chinese patients with Behçet's syndrome via cluster analysis of immune cells and clinical features.

Arthritis research & therapy·2026
Same journal

Artemisinin increases susceptibility to ferroptosis of fibroblast-like synoviocytes in rheumatoid arthritis.

Arthritis research & therapy·2026
See all related articles

Systemic lupus erythematosus research in 2006 highlighted immune system disturbances, including innate immunity components and cytokines. Promising lymphocyte-directed therapies are under clinical investigation for lupus treatment.

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
  • Understanding immune system dysregulation is crucial for SLE pathogenesis.

Purpose of the Study:

  • To review 2006 preclinical and clinical studies on SLE.
  • To explore immune system disturbances, including co-stimulation and cytokines.
  • To discuss emerging therapeutic strategies for SLE.

Main Methods:

  • Review of published reports from 2006 concerning SLE.
  • Analysis of studies focusing on immune system components and their role in lupus.
  • Evaluation of current and novel therapeutic approaches.

Main Results:

  • Increased knowledge of innate immune system components (Toll-like receptors, Fc receptors, complement receptors) and cytokines.

Related Experiment Videos

  • Identification of specific immune cells (dendritic cells, plasmacytoid cells, neutrophils) implicated in SLE pathogenesis.
  • Emerging insights into the complexity of lupus immunopathogenesis.

    • Conclusions:

    • Innate immune components and cytokines are increasingly recognized for their role in SLE.
    • Further research is needed to identify therapeutic targets and biomarkers.
    • Lymphocyte-directed therapies show promise in clinical investigations for SLE.